Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06479096 · ClinicalTrials.gov registry record · NA
Four-Week Oral Malodor and Clinical Safety for a Concentrated Cosmetic Mouthwash
A NA study, sponsored by Johnson & Johnson Consumer and Personal Products Worldwide.
- Completed
- Registry status
- NA
- Development phase
- 166
- Enrollment target
NCT06479096: Completed NA study, sponsored by Johnson & Johnson Consumer and Personal Products Worldwide.
NCT06479096 is a NA study that has completed, run by Johnson & Johnson Consumer and Personal Products Worldwide. The registered enrollment target is 166 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06479096, a NA study, has completed, sponsored by Johnson & Johnson Consumer and Personal Products Worldwide.
- COMPLETED
- Registry status
- NA
- Development phase
- 166 participants
- Enrollment target
Study Summary
The objective of this study is to evaluate the safety of the concentrated mouthwash prototypes, and to evaluate the efficacy of the concentrated mouthwash prototypes in the control of oral malodor compared to a comparator mouthwash and a negative control.
Primary Outcome
Mean malodor intensity will be independently assessed by three odor trained judges 60 minutes after product use on Day 0 using the following scale: 0 = No appreciable odor, 1 = Barely noticeable odor, 2 = Slight but clearly noticeable odor, 3 = Moderate odor, 4 = Strong odor, 5 = Extremely foul odor
Interventions
- OTHER Brush / Espresso Mild Prototype
- OTHER Brush / Espresso Intense Prototype
- OTHER Brush / Fresh Breath Oral Rinse
- OTHER Brush / Hydroalcohol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 166 participants |
| Start Date | 2024-07-15 |
| Est. Completion | 2024-09-12 |
| Phase | NA |
What the finished NCT06479096 record still lists
NCT06479096 is an interventional study that assigns participants to a tested intervention. The registered 166 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower).
The record links to 0 conditions, and to 4 interventions - of which Brush / Espresso Mild Prototype is the first listed.
NCT06479096 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06479096 about?
NCT06479096 is a clinical study titled "Four-Week Oral Malodor and Clinical Safety for a Concentrated Cosmetic Mouthwash". The objective of this study is to evaluate the safety of the concentrated mouthwash prototypes, and to evaluate the efficacy of the concentrated mouthwash prototypes in the control of oral malodor compared to a comparator mouthwash and a negative control.
What is the current status of trial NCT06479096?
This trial is currently completed. It is a NA study. The enrollment target is 166 participants. The study started on 2024-07-15. Estimated completion is 2024-09-12.
What interventions are being tested in trial NCT06479096?
The interventions under investigation include: Brush / Espresso Mild Prototype (OTHER), Brush / Espresso Intense Prototype (OTHER), Brush / Fresh Breath Oral Rinse (OTHER), Brush / Hydroalcohol (OTHER).
Who is sponsoring clinical trial NCT06479096?
This trial is sponsored by Johnson & Johnson Consumer and Personal Products Worldwide, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06479096's enrollment target sits among peer trials
166 625th of 2000 higher than 1,375 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02747303 · 166 participants · Phase 2
Frameless Stereotactic Radiosurgery for Intact Brain Metastases
- NCT03806283 · 166 participants
Mechanisms of Pregnancy Vascular Adaptations
- NCT04040452 · 166 participants · Phase 4
Continuous vs Intermittent Ketorolac for Pain Control in Peds CV Surgery
- NCT04375813 · 166 participants · Phase 2
Trial of Encapsulated Rapamycin (eRapa) for Bladder Cancer Prevention
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI